BioSpace News Archive

Biotech Bay

Study Finds Z-CAN Program, Supported by Medicines360, Increased Use of LARCs by Women in Puerto Rico During Zika Outbreak

Medicines360, a global nonprofit women’s health pharmaceutical company with a mission of expanding access to quality medicines, today highlighted a new report published in The Lancet Public Health.

January 25, 2018
·
3 min read
Onxeo Receives EPO Intent-to-Grant Notice for Key AsiDNA™ Patent, Extending IP Protection in Europe Until 2031

Onxeo today announced having received a communication from the European Patent Office (EPO) informing the Company of its intent to grant a new patent covering AsiDNA, Onxeo’s first-in-class DNA break repair inhibitor candidate in all countries of the European Union (EU).

January 25, 2018
·
5 min read
Biotech Bay

MultiVir Reports Reversal of Immunotherapy Resistance by Tumor Suppressor Immune Gene Therapy

MultiVir Inc presented updated data at the annual ASCO-SITC Clinical Immuno-Oncology Symposium demonstrating the ability of its immune gene therapies to reverse resistance to immune checkpoint inhibitor therapy.

January 25, 2018
·
3 min read
Valeant to Shave an Additional $200M From Its Mountain of Debt

When the debt is repaid next week, Valeant will have reduced its debt by more than $6.7 billion since the end of the first quarter of 2016..

January 25, 2018
·
2 min read
Business

Omnicell to Release Fourth Quarter 2017 Earnings Results on February 1, 2018

Omnicell will hold a conference call on Thursday, February 1, 2018, to discuss the Company’s Fourth Quarter 2017 financial results.

January 25, 2018
·
2 min read
Policy

Alnylam Announces EMA Acceptance of MAA for Patisiran for the Treatment of Hereditary ATTR (hATTR) Amyloidosis

The filing of the MAA was previously announced on December 18, 2017.

January 25, 2018
·
8 min read
Business

Endologix, Inc. to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on February 21, 2018

The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

January 25, 2018
·
1 min read
Business

Vascular Insights Announces New CEO

The company’s Board of Directors has appointed James P. Ott as President and CEO.

January 25, 2018
·
1 min read
Pharm Country

Senseonics Announces Proposed Convertible Senior Subordinated Notes Offering

Senseonics today announced a proposed underwritten offering, subject to market and other conditions, of convertible senior subordinated notes due 2023 (the Notes).

January 25, 2018
·
4 min read
Policy

BIOLASE Rejects Frivolous, Abusive Patent Litigation

Biolase responded to the latest attempt by CAO Group to use patent litigation to try to improve its competitive position in the marketplace.

January 25, 2018
·
5 min read